GlassScriptPhysician profile
Karen Fox
NPI 1821153925
$3,688.15
in general payments reported to CMS, 2019-2025
24 companies · $338 in 2025
The $338 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,298 · 2022: $1,291 · 2023: $454 · 2024: $306 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,099.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,098.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $804.45 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $537.87 | 2021-2022 | |
| Inspire Medical Systems, INC. | $269.24 | 2023-2025 | Inspire |
| Axsome Therapeutics, INC. | $240.82 | 2024-2025 | Auvelity |
| Intercept Pharmaceuticals, INC. | $234.11 | 2021 | |
| Gilead Sciences, INC. | $219.65 | 2021-2024 | Epclusa |
| Astrazeneca Pharmaceuticals LP | $210.67 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $159.07 | 2022-2025 | |
| Ironwood Pharmaceuticals, INC | $136.01 | 2021-2022 | |
| Edwards Lifesciences Corporation | $135.45 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Teva Pharmaceuticals USA, INC. | $110.00 | 2023 | Austedo Xr |
| Janssen Scientific Affairs, LLC | $107.53 | 2021 | |
| Novo Nordisk INC | $98.10 | 2024 | |
| Ferring Pharmaceuticals INC. | $83.32 | 2021-2022 | |
| Braintree Laboratories, INC. | $56.88 | 2021-2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $53.63 | 2021-2022 | |
| Qol Medical, LLC | $47.84 | 2021 | |
| Ardelyx, INC. | $36.02 | 2022 | |
| Fujifilm Healthcare Americas Corporation | $34.59 | 2022 | |
| Ethicon US, LLC | $31.31 | 2021 | |
| Merck Sharp & Dohme LLC | $24.91 | 2021 | |
| Genzyme Corporation | $19.53 | 2022 | |
| Daiichi Sankyo INC. | $18.69 | 2021 | |
| Medtronic, INC. | $18.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Fox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.